For the year ending 2025-12-31, EDIT made $40,520K in revenue. -$160,060K in net income. Net profit margin of -395.01%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Collaboration and other research and development revenues | 40,520 | |||
| Research and development | 89,953 | |||
| General and administrative | 49,903 | |||
| Restructuring and impairment charges | 60,674 | |||
| Total operating expenses | 200,530 | |||
| Operating loss | -160,010 | |||
| Interest expense related to sale of future revenues | 6,171 | |||
| Interest income, net | 8,310 | |||
| Other expense, net | -2,189 | |||
| Total other income (expense), net | -50 | |||
| Net loss | -160,060 | |||
| Basic EPS | -1.8 | |||
| Diluted EPS | -1.8 | |||
| Basic Average Shares | 88,745,908 | |||
| Diluted Average Shares | 88,745,908 | |||
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)